TG Therapeutics Trial Site — Hackensack, New Jersey

TG Therapeutics Trial Site is a clinical research site located in Hackensack, New Jersey, United States 07601.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

TG Therapeutics Trial Site has participated in 1 clinical trials.

Therapeutic areas: Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Peripheral T-Cell Lymphoma.

Sponsors: TG Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for TG Therapeutics Trial Site?

TG Therapeutics Trial Site has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has TG Therapeutics Trial Site conducted?

TG Therapeutics Trial Site has 1 clinical trials on record. Their work covers Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Peripheral T-Cell Lymphoma.

Is TG Therapeutics Trial Site accredited by Crixeo Health?

TG Therapeutics Trial Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about TG Therapeutics Trial Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.